Cargando…
Comparison of Carboplatin and Doxorubicin‐Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma
BACKGROUND: Many chemotherapy protocols have been reported for treatment of canine appendicular osteosarcoma (OSA), but outcome comparisons in a single population are lacking. OBJECTIVE: To evaluate the effects of protocol and dose intensity (DI) on treatment outcomes for carboplatin and doxorubicin...
Autores principales: | Selmic, L.E., Burton, J.H., Thamm, D.H., Withrow, S.J., Lana, S.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857984/ https://www.ncbi.nlm.nih.gov/pubmed/24512451 http://dx.doi.org/10.1111/jvim.12313 |
Ejemplares similares
-
Prognostic value of fluorine(18) flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma
por: Griffin, Lynn R., et al.
Publicado: (2019) -
Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma
por: Story, A.L., et al.
Publicado: (2017) -
Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy
por: Heishima, Kazuki, et al.
Publicado: (2019) -
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study
por: London, Cheryl A., et al.
Publicado: (2015) -
Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
por: Morges, M.A., et al.
Publicado: (2014)